Insulet Corp (PODD)
174.43
+1.01
(+0.58%)
USD |
NASDAQ |
May 03, 16:00
174.46
+0.03
(+0.02%)
After-Hours: 20:00
Insulet Accounts Payable (Quarterly): 19.20M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 19.20M |
September 30, 2023 | 77.80M |
June 30, 2023 | 107.50M |
March 31, 2023 | 85.90M |
December 31, 2022 | 30.80M |
September 30, 2022 | 62.10M |
June 30, 2022 | 57.20M |
March 31, 2022 | 52.20M |
December 31, 2021 | 37.70M |
September 30, 2021 | 58.00M |
June 30, 2021 | 49.30M |
March 31, 2021 | 59.10M |
December 31, 2020 | 54.10M |
September 30, 2020 | 57.00M |
June 30, 2020 | 35.60M |
March 31, 2020 | 36.40M |
December 31, 2019 | 54.50M |
September 30, 2019 | 21.24M |
June 30, 2019 | 24.75M |
March 31, 2019 | 26.83M |
December 31, 2018 | 25.50M |
September 30, 2018 | 26.84M |
June 30, 2018 | 25.19M |
March 31, 2018 | 33.85M |
December 31, 2017 | 24.41M |
Date | Value |
---|---|
September 30, 2017 | 28.65M |
June 30, 2017 | 12.24M |
March 31, 2017 | 6.413M |
December 31, 2016 | 13.16M |
September 30, 2016 | 18.21M |
June 30, 2016 | 21.60M |
March 31, 2016 | 13.48M |
December 31, 2015 | 15.21M |
September 30, 2015 | 15.61M |
June 30, 2015 | 17.92M |
March 31, 2015 | 14.25M |
December 31, 2014 | 14.66M |
September 30, 2014 | 17.73M |
June 30, 2014 | 18.61M |
March 31, 2014 | 20.98M |
December 31, 2013 | 19.36M |
September 30, 2013 | 15.12M |
June 30, 2013 | 11.44M |
March 31, 2013 | 8.544M |
December 31, 2012 | 9.361M |
September 30, 2012 | 16.22M |
June 30, 2012 | 13.69M |
March 31, 2012 | 16.11M |
December 31, 2011 | 11.42M |
September 30, 2011 | 8.604M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
19.20M
Minimum
Dec 2023
107.50M
Maximum
Jun 2023
51.60M
Average
54.10M
Median
Dec 2020
Accounts Payable (Quarterly) Benchmarks
Abbott Laboratories | 4.295B |
Stryker Corp | 1.246B |
Tandem Diabetes Care Inc | 49.59M |
Becton Dickinson & Co | -- |
ResMed Inc | 177.44M |